News | March 13, 2025
Alkem launches generic empagliflozin and its combinations in India under ‘Empanorm’
Empagliflozin is used in the treatment of type-2 diabetes mellitus, chronic kidney disease and heart failure
Empagliflozin is used in the treatment of type-2 diabetes mellitus, chronic kidney disease and heart failure
These appointments align with the group’s philosophy of having a strong and independent board with exceptional industry experts, ensuring strategic guidance and effective governance
Empagliflozin and its Fixed Drug Combinations (FDCs) have been launched under the brand names Glempa, Glempa –L and Glempa-M
Illexcor is developing a first-in-class oral drug that directly targets the root cause of SCD
The programme will take place on the 2nd Sunday of every month
The MDR certification reafirms that these products meet the highest safety, quality, and regulatory standards
Amplitude Surgical is a European MedTech leader in high-quality, lower-limb orthopaedic technologies
Havix was incorporated under the laws of the State of Delaware on February 17, 2015
The European regulator will conduct a re-inspection of the facility to verify the compliance
Announces Rs. 317 crore investment in new recycling plant
Subscribe To Our Newsletter & Stay Updated
